Expert Opinion on Drug Safety,volume 9,issue 2  (03-2014)

Period of time： 2014年2期

Publisher： Informa Healthcare

Founded in： 2002

Total resources： 54

ISSN： 1474-0338

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Expert Opinion on Drug Safety,volume 9,issue 2

Menu

Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases

By Kontoghiorghes G J,Kolnagou A,Peng C-T,Shah S V,Aessopos A in (2010)

Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp. 201-206

Informa Healthcare

Abstract Access to resources Recommend Favorite

Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience

By Li Jia,Merl Manyee,Lee Mike X,Kaley Kristin,Saif Muhammad W in (2010)

Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp. 207-213

Informa Healthcare

Abstract Access to resources Recommend Favorite

Drug interactions with antiretrovirals and warfarin

By Liedtke Michelle D,Rathbun R Chris in (2010)

Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp. 215-223

Informa Healthcare

Abstract Access to resources Recommend Favorite

Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature

By Holstein Andreas,Stege Helger,Kovacs Peter in (2010)

Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp. 225-231

Informa Healthcare

Abstract Access to resources Recommend Favorite

Safety and efficacy of over- the-counter cough and cold medicines for use in children

By Vassilev Zdravko P,Kabadi Shaum,Villa Raul in (2010)

Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp. 233-242

Informa Healthcare

Abstract Access to resources Recommend Favorite

Diuretics in clinical practice. Part I: mechanisms of action, pharmacological effects and clinical indications of diuretic compounds

By Sarafidis Pantelis A,Georgianos Panagiotis I,Lasaridis Anastasios N in (2010)

Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp. 243-257

Informa Healthcare

Abstract Access to resources Recommend Favorite

Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy

By Sarafidis Pantelis A,Georgianos Panagiotis I,Lasaridis Anastasios N in (2010)

Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp. 259-273

Informa Healthcare

Abstract Access to resources Recommend Favorite

Toxicity of sorafenib: clinical and molecular aspects

By Blanchet Benoit,Billemont Bertrand,Barete Stéphane,Garrigue Hélène,Cabanes Laure,Coriat Romain,Francès Camille,Knebelmann Bertrand,Goldwasser François in (2010)

Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp. 275-287

Informa Healthcare

Abstract Access to resources Recommend Favorite

Benefit–risk assessment: the use of clinical utility index

By Ouellet Daniele in (2010)

Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp. 289-300

Informa Healthcare

Abstract Access to resources Recommend Favorite

Safety profile of new anticancer drugs

By Mansi Laura,Thiery-Vuillemin Antoine,Nguyen Thierry,Bazan Fernando,Calcagno Fabien,Rocquain Julien,Demarchi Martin,Villanueva Cristian,Maurina Tristan,Pivot Xavier in (2010)

Expert Opinion on Drug Safety,volume 9,issue 2 , Vol. 9, Iss. 2, 2010-03 , pp. 301-317

Informa Healthcare

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 15 item(s)